Why medtech should keep its lobbying expectations low in 2017

Political chaos is lowering expectations when it comes to the medtech industry getting much done in Congress this year, says Clayton Hall, VP of government affairs for the Medical Device Manufacturers Association.

When it comes to permanent repeal of the 2.3% medical device excise tax that was part of the 2010 Affordable Care Act, there are fewer legislative opportunities, Hall said during a webinar hosted Aug. 23 by Medmarc Insurance Group.

“There are opportunities – fewer and fewer though to get full repeal. So the likeliest outcome right now is probably an additional suspension. But there are some opportunities to get full repeal. And that’s what we’re fighting for,” Hall said.

Get the full story on our sister site, Medical Design & Outsourcing.

The post Why medtech should keep its lobbying expectations low in 2017 appeared first on MassDevice.

from MassDevice http://ift.tt/2vGR723